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ABSTRACT Nonribosomal peptide synthases produce short peptides in a manner
that is distinct from classical mRNA-dependent ribosome-mediated translation. The
Mycobacterium tuberculosis genome harbors a nonribosomal peptide synthase gene,
nrp, which is part of a gene cluster proposed to be involved in the biosynthesis of
isonitrile lipopeptides. Orthologous clusters are found in other slow-growing patho-
genic mycobacteria and actinomycetes. To probe the role of the nrp gene in infec-
tion, we generated an nrp deletion mutant in M. tuberculosis H37Rv and tested its
virulence in immunocompetent (C57BL/6) mice. The nrp mutant strain displayed
lower initial growth rates in the lungs and a defective dissemination to the spleens
of infected mice. Mice infected with the mutant strain also survived for twice as
long as those infected with wild-type M. tuberculosis and, remarkably, showed sub-
dued pathology, despite similar bacterial loads at later stages of infection. The differ-
ences in the course of infection between wild-type and nrp mutant strains were ac-
companied by distinct dynamics of the immune response. Most strikingly, the nrp
mutant was highly attenuated in immunodeﬁcient (SCID-, recombination activating 2
[RAG2]-, and gamma interferon [IFN-]-deﬁcient) mice, suggesting that macrophages
control the nrp mutant more efﬁciently than they control the wild-type strain. How-
ever, in the presence of IFN-, both strains were equally controlled. We propose that
the nrp gene and its associated cluster are drivers of virulence during the early
stages of infection.
IMPORTANCE Over 10 million people developed tuberculosis (TB) in 2016, and over
1.8 million individuals succumbed to the disease. These numbers make TB the ninth
leading cause of death worldwide and the leading cause from a single infectious
agent. Therefore, ﬁnding novel therapeutic targets in Mycobacterium tuberculosis, the
pathogen that causes most cases of human TB, is critical. In this study, we reveal a
novel virulence factor in M. tuberculosis, the nrp gene. The lack of nrp highly attenu-
ates the course of M. tuberculosis infection in the mouse model, which is particularly
relevant in immune-deﬁcient hosts. This is very relevant as TB is particularly incident
in immune-suppressed individuals, such as HIV patients.
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Tuberculosis (TB) remains a leading cause of death by an infectious agent. Indeed,TB, caused by Mycobacterium tuberculosis, kills over 1.8 million people, afﬂicts over
10 million new individuals per year, and is estimated to exist in a latent form in
one-fourth of the world’s population (1). To reach the milestone of less than one TB
case per million individuals, set by the World Health Organization (WHO) for 2050,
numerous roadblocks will have to be overcome, notably, the development of more
efﬁcient vaccines and therapies. Success on these fronts requires a greater understand-
ing of the mechanisms underlying the success of M. tuberculosis as a pathogen. In this
regard, a variety of genetic strategies have been employed to unlock novel virulence
factors in M. tuberculosis and hence druggable targets (2–4).
Nonribosomal peptide synthases (NRPSs) are large multifunctional proteins involved
in the biosynthesis of short peptides in a manner that is distinct from the ribosome-
mediated translation of mRNA (5). The genes encoding NRPSs are predominantly found
in bacteria and fungi that produce secondary metabolites (6). The short peptides
produced by NRPSs usually form part of a larger more complex molecule. The genomes
of mycobacteria, including the TB-causing M. tuberculosis, contain genes encoding
NRPSs. While NRPSs in environmental bacteria are often associated with antibiotic and
other secondary metabolite production (6), mycobacterial NRPSs are mainly involved in
the production of components of complex cell wall lipids and siderophores (7, 8).
Rv0101 (nrp) is an M. tuberculosis H37Rv gene annotated as a NRPS (9). The gene
encodes a putative bimodular NRPS containing seven catalytic domains (10, 11),
including an adenylation domain with predicted substrate speciﬁcity for lysine and
phenylalanine. nrp is located in a cluster of genes with potentially linked functions:
Rv0097 encodes a putative oxidase, Rv0098 encodes a long-chain fatty acyl-coenzyme
A (fatty acyl-CoA) thioesterase (12, 13), and FadD10 (Rv0099) is a fatty acyl-AMP ligase
that catalyzes the transfer of fatty acyl chains to an acyl carrier protein encoded by
Rv0100 (10). The knowledge about the precise function of nrp and its associated cluster
is based solely on the structural characterization and in vitro enzyme assays with
heterologously expressed and puriﬁed M. tuberculosis and Mycobacterium marinum
proteins and suggests a role in the production of a novel lipopeptide with isonitrile
functionality (10, 14).
Importantly, several in vitro and in vivo infection studies have highlighted a potential
role for nrp in the pathogenesis of TB. Speciﬁcally, nrp was reported as a nonessential
gene for in vitro growth by transposon mutagenesis (15) but was otherwise required for
growth in the spleens of C57BL/6J mice (16). Additionally, the gene cluster spanning
Rv0096-Rv0101 was shown to be critical for survival in mice (17). Furthermore, Nrp was
reported to be the most abundant M. tuberculosis protein in the lungs of infected
guinea pigs by day 30 postinfection, while being undetected at 90 days postinfection
(18). Overall, these reports indicate that the cryptic metabolite produced by the nrp
cluster is likely to play a role in virulence, which calls for a deeper investigation of nrp
in the context of M. tuberculosis biology and infection.
In this study, we sought to query the role of the nrp gene in the pathogenesis of TB
in the mouse model of infection. Our strategy consisted of the generation of M.
tuberculosis mutant strains lacking the nrp gene. We herein reveal an important role for
nrp in the virulence of M. tuberculosis, likely mediating the initial interaction of the
bacteria with the host macrophages. We show that nrp-deﬁcient M. tuberculosis grows
at a lower rate in immunocompetent and immunodeﬁcient mice, causing less lung
pathology and associated with signiﬁcantly increased survival rates.
RESULTS
nrp cluster in mycobacteria. The M. tuberculosis nrp gene (Rv0101) encodes a
bimodular NRPS with domains predicted to activate Lys and Phe (10, 11, 14). The gene
is present in a cluster of 5 genes including nrp plus Rv0097 to Rv0100. A sequence
comparison analysis of the nrp cluster among 72 genomes from species representative
of the phylogeny of the genus Mycobacterium (19) revealed that this cluster is absent
in most rapid-growing nontuberculous mycobacteria (NTM), commonly found in the
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environment and considered nonpathogenic (Fig. 1A). The NTM exceptions harboring
genes of the nrp cluster with more than 40% identity score to the genes of M.
tuberculosis were Mycobacterium peregrinum, Mycobacterium fortuitum, Mycobacterium
mageritense, Mycobacterium tusciae, and Mycobacterium thermoresistible. Most slow-
growing mycobacteria (31 of 48 [64.6%]) harbor orthologs to the M. tuberculosis
Rv0097-Rv0101 genes with identity scores above 45% (Fig. 1A). This includes other
pathogenic species, such as Mycobacterium leprae (50.6% identity) and Mycobacterium
ulcerans (55.2% identify) (Fig. 1A). A synteny analysis showed that the nrp cluster is
located in a homologous genomic DNA region shared by the chromosomes of the
species of the Mycobacterium tuberculosis complex (MTBC) and M. leprae, without major
sequence rearrangements. The exception is the considerably smaller size of the nrp
gene in M. leprae compared to the nrp genes found in species from the MTBC (4,206 bp
in M. leprae NC_002677 versus 7,539 bp in M. tuberculosis NC_000962) (Fig. 1B). As a
result of this difference, the structural prediction is that the nrp gene found in MTBC
strains encodes a bimodular NRPS, whereas the homologues from other mycobacteria,
such as M. leprae, encode a single NRPS module. A detailed analysis of the level of
nucleotide diversity of these genes within the MTBC was obtained by the analysis of
220 M. tuberculosis genomes from 7 MTBC lineages (20) and showed that the level
FIG 1 The nrp cluster is highly conserved among the MTBC and slow-growing species of the genus Mycobacterium. (A) Sequence identity scores of the nrp
cluster were obtained by querying the M. tuberculosis H37Rv sequences Rv0097-Rv0101 against a local database of 72 genomes of species representative of the
phylogeny of the genus Mycobacterium (19). The genomics sequences include complete genomes and whole-genome shotgun sequences. The highest
percentage (dark green) corresponds to the longest and most elevated sequence identities. (B) Synteny of the genome sections harboring the nrp cluster in
M. tuberculosis, M. bovis, M. canettii, and M. leprae. The green shading indicate homologous DNA regions shared by the four chromosomes without major
sequence rearrangements. The genes of the nrp cluster are highlighted in yellow. (C) Nucleotide diversity () level of the M. tuberculosis genes Rv0097, fcoT,
fad10, Rv0100, and nrp and the complete genome across a set of 220 genomes, including strains from lineage 1 to 7 of the MTBC.
nrp Is a Virulence Factor for M. tuberculosis
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of nucleotide diversity of these genes is below the genome-wide level (Fig. 1C). Thus,
the comparative genome analysis suggests that the nrp cluster is highly conserved
among slow-growing members of the Mycobacterium genus, highlighting the larger
size of the nrp gene as the most characteristic MTBC-associated feature.
Loss of the nrp gene results in attenuation ofM. tuberculosis H37RV in mice. To
investigate the role of nrp in the virulence of slow-growing mycobacteria, we ﬁrst
generated a null mutant of M. tuberculosis H37Rv nrp by using specialized transduction
to replace nrp with a hygromycin resistance cassette. Subsequently, we generated a
complemented strain (nrp-comp) by introducing an integrative shuttle cosmid vector
(containing an M. tuberculosis H37Rv cosmid fragment spanning Rv0096 to Rv0109) into
the Δnrp mutant (see Fig. S1A in the supplemental material). To control for possible
polar effects of the Δnrp deletion on the adjacent gene Rv0102, the expression of this
gene was monitored in either of the recombinant M. tuberculosis strains. We found that
the expression patterns of Rv0102 were similar in mutant and complemented bacteria
(Fig. S1B). Furthermore, the axenic growth of the two engineered M. tuberculosis H37Rv
strains was identical and similar to that of the wild-type (WT) H37Rv (Fig. S1C), showing
no major growth defects imposed by the absence of nrp. Additionally, the Δnrp strain
retained its acid-fast properties (Fig. S1D).
To assess the role of nrp in the pathogenesis of M. tuberculosis in the murine model
of infection, immunocompetent (C57BL/6) mice were infected with aerosols of WT,
Δnrp, or nrp-comp strains of M. tuberculosis H37Rv. Bacterial burdens in the lungs and
spleens of infected mice were analyzed at different time points postinfection (Fig. 2A
and B). At 3 weeks postinfection, fewer colonies of the Δnrp strain were found in
infected lungs than of the WT or nrp-comp strains (Fig. 2A). However, the lung bacterial
loads of all three strains were similar at later time points (Fig. 2A), indicating that the
Δnrp strain eventually grew to a level comparable to that of the WT strain in the long
term. The differences in bacterial loads in the spleen were stark between the strains,
with considerably fewer bacteria cultured from the spleens of mice infected with the
Δnrp strain (Fig. 2B). Furthermore, we observed a signiﬁcant difference in the survival
of mice infected with the different strains. While all mice in groups infected with WT or
nrp-comp strains died prior to 325 days postinfection, those infected with the Δnrp
strain survived for up to 700 days postinfection (Fig. 2C). Given that we were able to
complement the growth phenotypes in C57BL/6 (Fig. 2A to C), we chose to focus our
comparison of the Δnrp and nrp-comp strains for all further studies described below in
an effort to limit the number of mice used in our experiments.
To further explore the growth kinetics of the Δnrp strain in the early stages of
infection, we repeated the infection of C57BL/6 mice to monitor CFU levels in lungs
from day 14 to up to 90 days postinfection. The difference in CFU between Δnrp-strain-
and nrp-comp-strain-infected mice was readily visible on day 14 postinfection, corre-
sponding to a 48-fold lower bacterial burden (1.683 log10 average difference) in the
case of mice infected with the Δnrp strain on day 20. From day 30 postinfection and up
to day 90, the Δnrp strain reached lung bacillary counts comparable to those of the
nrp-comp strain (Fig. 2D), as observed before (Fig. 2A).
nrp-strain-infected mice develop less lung pathology. In addition to the dif-
ferences observed in the progression of bacterial burdens, a distinct phenotype was
also observed in lung histopathological features during infection with the Δnrp strain
versus the nrp-comp strain (Fig. 2E and F). Speciﬁcally, by day 20 postinfection, no
discernible lesions were observed in the lungs of Δnrp-strain-infected animals, whereas
multiple small inﬂammatory inﬁltrates were already present in the lungs of animals
infected with the nrp-comp strain (Fig. 2E and F). This was likely due to the differences
in bacterial burdens observed at this time point (Fig. 2D). By day 30 postinfection, the
lesions in the lungs of mice infected with the nrp-comp strain were larger than those
in mice infected with the Δnrp strain (Fig. 2E and F), even though both presented the
same bacterial burden (Fig. 2D). Remarkably, the histological differences were main-
tained throughout the chronic stage of infection, as on day 90 postinfection, the
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animals infected with the nrp-comp strain still presented a greater degree of pathology
than those infected with the Δnrp strain (Fig. 2E and F), despite the fact that the
bacterial burdens had been similar in both cases for 60 days (Fig. 2D). This subdued
pathology may explain the longer survival of mice infected with the Δnrp strain
(Fig. 2C).
Kinetics of the immune response is altered in nrp-strain-infected mice. So far,
our data indicated that in the absence of nrp, mice had a better ability to control the
infection at initial time points and showed a striking lesser pathology even at late time
points of infection. These ﬁndings suggest that a differential immune response may be
occurring in the absence of Nrp function. To test this hypothesis, we next investigated
the dynamics of immune cell populations elicited during infection with Δnrp or
nrp-comp strains. We focused on myeloid (alveolar macrophages, inﬂammatory mono-
cytes, and neutrophils) (Fig. 3A to C) and lymphoid (CD4 T cells, CD8 T cells, and B
cells) (Fig. 3D to F) cells known to be relevant to the pathogenesis of TB. Whereas no
substantial differences were found throughout the infection with either strain in
FIG 2 Loss of the nrp gene results in attenuation of M. tuberculosis H37Rv in mice. C57BL/6 mice were infected by
aerosol exposure to H37Rv (WT), Δnrp, or nrp-comp strains. At the indicated time points, the lungs (A and D) and
spleens (B) of infected mice were collected and the bacterial burden determined by CFU enumeration. (C) The
weights of the animals were monitored to determine survival curves. On days 20, 30, and 90 postinfection, lung
pathology (E and F) was determined by hematoxylin and eosin (H&E) staining and morphometric analysis of the
right upper lobes of infected lungs. Data are shown as the means  standard errors of the means (SEMs) from 5
independent animals in at least 2 independent experiments. The pictures in panel F are of one animal represen-
tative of the experimental group; 40 magniﬁcation. Statistical analysis was performed with a two-way ANOVA
using Sidak’s test for multiple comparisons (A, B, D, and E) or with log-rank (Mantel-Cox) test for the Kaplan-Meier
curves (C). * and  refer to statistical differences between Δnrp and nrp-comp strains or Δnrp and WT strains,
respectively. * or , P 0.05; **, P 0.01; ***, P 0.001; **** or , P 0.0001.
nrp Is a Virulence Factor for M. tuberculosis
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alveolar macrophages (Fig. 3A), neutrophils (Fig. 3C), CD8 T cells (Fig. 3E), and B cells
(Fig. 3F), signiﬁcantly fewer inﬂammatory monocytes (Fig. 3B) and CD4 T cells (Fig. 3D)
were detected at day 20 postinfection in the lungs of mice infected with the Δnrp strain.
These differences were attenuated by day 30 postinfection and were no longer present
FIG 3 Lack of nrp alters the dynamics of the lung immune response to infection. (A to H) At the indicated time points postinfection,
the lungs of C57BL/6 mice infected via aerosol exposure to Δnrp or nrp-comp strains were harvested, a cellular suspension was
prepared, and the indicated immune cell populations were determined by ﬂow cytometry. The gating strategy is shown in Fig. S2
in the supplemental material. (I) On day 20 postinfection, the expression of CCL2, CCL7, IFN-, and TNF was determined by real-time
PCR, as described in Materials and Methods. Data are shown as the means  SEMs from 5 independent animals in at least 2
independent experiments. The initial bacterial burdens were log10 1.86 log10 0.04460 and log10 1.931 log10 0.0822 for Δnrp and
nrp-comp strains, respectively. Statistical analysis was performed with a two-way ANOVA using Sidak’s test for multiple comparisons.
*, P 0.05; **, P 0.01; ***, P 0.001; ****, P 0.0001.
Bhatt et al.
September/October 2018 Volume 3 Issue 5 e00352-18 msphere.asm.org 6
 o
n
 January 28, 2019 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
by day 90 postinfection (Fig. 3B and D). In addition to the decreased numbers of
inﬂammatory monocytes and CD4 T cells observed 20 days postinfection in the
absence of nrp expression, the number of activated cells within these populations, as
measured by the expression of surface markers major histocompatibility complex
(MHC) class II and CD44, was also decreased (Fig. 3G and H). The gating strategy using
in the deﬁnition of these populations is presented in Fig. S2.
At the molecular level, the diminished recruitment of inﬂammatory monocytes seen in
the Δnrp strain may be explained by a lower expression of CCL2 and CCL7, chemokines that
play a role in the recruitment of myeloid cells to the site of infection (21), in the lungs of
these animals (Fig. 3I). In line with a lower frequency of activated CD4 T cells in
Δnrp-strain-infected animals, a decreased expression of gamma interferon (IFN-) was
observed in the lungs of these animals compared to that in nrp-comp-strain-infected mice
(Fig. 3I). Tumor necrosis factor (TNF), another inﬂammatory mediator during TB, is also
expressed at a lower level upon infection with the Δnrp strain (Fig. 3I).
In all, the absence of nrp function in M. tuberculosis improves the host’s ability to
control bacterial growth early postinfection, which is reﬂected in a lower bacterial
burden. This is accompanied by diminished inﬂammatory monocyte and CD4 T cell
recruitment and activation, as well as decreased expression of inﬂammatory mediators,
which in the long-term likely lower the progression of lung pathology. Thus, these data
suggest Nrp as a novel virulence factor for M. tuberculosis, altering the initial phases of
infection and the immune response, but with a long-lasting impact on the pathology
developed at the site of infection.
nrp mutant is attenuated for growth in immune-deﬁcient mice. Our ﬁndings
point to a role for nrp during the early stages of M. tuberculosis infection. These ﬁndings
led us to investigate for possible differences in the course of infection with Δnrp or
nrp-comp strains in immune-deﬁcient mice. We ﬁrst infected SCID mice with aerosols
of WT H37Rv, Δnrp, or nrp-comp strains and observed a remarkably longer survival rate
for mice infected with the Δnrp mutant (see Fig. S3). As with the above-described
experiments performed with immunocompetent mice, given that the survival patterns
were restored upon complementation, we performed all subsequent experiments with
immunodeﬁcient mice using the Δnrp and Δnrp-comp strains. Next, we infected
recombination activating 2 (RAG2)-deﬁcient (/) mice and IFN-/ mice. Both
mouse strains are unable to control M. tuberculosis growth and typically succumb to
infection 40 to 50 days after infection (22, 23). In line with this, both RAG2/ and
IFN-/ mice succumbed to infection with the nrp-comp strain (Fig. 4A and B).
Strikingly, both mouse strains infected with the Δnrp mutant registered a signiﬁcantly
higher survival rate (average survival of 114 days against 44.7 days in RAG2/ mice
and 99 days against 45 days in IFN-/mice). An analysis of lung CFU counts indicated
that the Δnrp mutant grew at a lower rate in the lungs of infected RAG2/ mice
(Fig. 4C). However, at the time of death, the lung bacterial burdens observed for each
nrp strain were identical in both RAG2/ (Fig. 4C) and IFN-/ (Fig. 4D) animals.
Furthermore, at the time of death, the lungs of RAG2/ (Fig. 4E) and IFN-/ (Fig. 4F)
mice infected with the Δnrp strain displayed signiﬁcantly less pathology than their
nrp-comp counterparts. Therefore, our data are indicative that in the absence of
acquired immunity or IFN-, the attenuated M. tuberculosis growth due to the loss of
nrp function was much more prolonged, associating again with reduced pathology.
This set of data supports a more effective control of bacterial burden by the host’s
innate immunity, in the presence of limited pathology, in the absence of nrp function.
Primary macrophages are more efﬁcient at controlling the growth of the nrp
strain. Altogether, our ﬁndings suggest a more effective control of the Δnrp strain by
the host during the innate immune response. Since macrophages are one of the ﬁrst
types of cells to be infected by M. tuberculosis and to exert microbicidal functions (24),
we questioned whether the expression of nrp impacted the bacterial control by
infected macrophages. For this, we resorted to an in vitro system where mouse bone
marrow-derived macrophages (BMDM) or macrophages isolated from the peritoneal
nrp Is a Virulence Factor for M. tuberculosis
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FIG 4 Growth of Δnrp mutant is attenuated in immune-deﬁcient mice. C57BL/6 RAG2/ (A, C, and E)
and IFN-/ (B, D, and F) mice were infected by aerosol exposure to a low dose of the Δnrp or nrp-comp
strain. (A and B) The weights of the animals were monitored weekly up to day 30 and every 2 days
thereafter to determine the survival curves. At the indicated time points (C) or at the time of death (D),
the lungs of infected mice were collected and the bacterial burden was determined by CFU enumeration.
The lung pathology was determined on day 40 postinfection for RAG2/ (E) or at the time of death for
IFN-/ (F) animals. Shown are pictures from H&E staining for one animal representative of the
experimental group; 40 magniﬁcation. The initial bacterial burdens were log10 1.92 log10 0.069 and
log10 1.701 log10 0.0707 (RAG2/ experiment) and log10 1.92 log10 0.069 and log10 1.748 log10
0.0707 (IFN-/ experiment) for Δnrp and nrp-comp strains, respectively. BMDM (G and H) or pMac (G)
were infected with Δnrp or nrp-comp strains at an MOI of 1 in the absence (G) or presence (H) of
exogenous IFN-. On day 4 postinfection, the intracellular bacterial load was determined by CFU
enumeration. Data are shown as the means  SEMs from 8 independent animals (A to F) or from 6
replicate wells in 2 independent experiments (G and H). Statistical analysis was performed with log-rank
(Mantel-Cox) tests for the Kaplan-Meier curves (A and B) or two-way ANOVAs using Sidak’s tests for
multiple comparisons (C to H). *, P 0.05; ***, P 0.001; ****, P 0.0001.
Bhatt et al.
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cavity (pMac) were infected with either of the strains, and the intracellular bacterial
burden was assessed 96 h later. This time point ensured macrophage viability, thus
avoiding the phenotypes related to cell death, rather than intracellular bacterial
growth. The growth of the nrp-comp strain at this time point, in either of the macro-
phage types, was higher than that observed for the Δnrp strain (Fig. 4G). We then
investigated the impact of exogenous IFN- on the ability of BMDM to control the
nrp-deﬁcient and -complemented M. tuberculosis strains. Exogenous IFN- improved
the control of either of the strains by the macrophages, ablating the differences
observed in bacterial growth (Fig. 4H). Of note, the macrophages infected with either
of the M. tuberculosis strains showed similar patterns of cell viability and of cytokine
production (see Fig. S4), suggesting a speciﬁc phenotype linked to bacterial control in
the absence of Nrp. Altogether, these data support a virulence-associated role for Nrp
in M. tuberculosis infection during the initial interaction with host macrophages. How-
ever, intriguingly, once the macrophages become fully activated, the host advantage
over the Δnrp M. tuberculosis strain was lost. These in vitro ﬁndings are in line with the
in vitro data, where the attenuation of the nrp-deﬁcient M. tuberculosis strain is
particularly notable during the early phase of infection but lost once the acquired
immune response is established.
DISCUSSION
TB remains a devastating disease to mankind, with high human and economic tolls
(25, 26). To efﬁciently tackle TB, an improvement of several current tools is needed,
notably with regard to prevention, diagnosis, and treatment. Owing to the alarming
drug resistance rates, which caused 480,000 cases of complicated TB in 2016 (1), there
is a pressing need for the development of novel treatment strategies. In this context,
a clearer understanding of the key virulence factors in M. tuberculosis may help in
ﬁnding new vulnerable and druggable targets. Different experimental approaches have
been pursued for the identiﬁcation of essentialM. tuberculosis genes (2, 4, 16), including
target-based screening. In this study, we aimed at elucidating the role of the nrp gene
in the pathogenesis of TB, resorting to a genetically engineered nrp-deﬁcient mutantM.
tuberculosis strain, as well as in vitro and in vivo models of infection.
Previous studies reporting that the nrp gene harbored by M. tuberculosis is essential
for in vivo growth (16) and expressed during early time points postinfection (18)
support a role for the cryptic metabolite produced by Nrp during infection. Further-
more, our in silico analysis showed that nrp is part of a cluster of genes that is rare
among the mostly nonpathogenic rapid-growing NTMs and highly conserved among
the slow-growing pathogenic species of the genus Mycobacterium. Overall, these
ﬁndings support a role for the product of the nrp cluster in the pathogenesis of
infection by Mycobacterium species.
A previous screen aimed at ﬁnding M. tuberculosis persistence mutants in isoniazid-
treated mice identiﬁed a transposon mutant with an insertion upstream of Rv0097, a
gene encoding a putative oxodoreductase and possibly also involved in the biosyn-
thesis pathway of the cryptic metabolite associated with nrp (17). The infection of WT
mice through an intravenous route showed that the transposon mutant was attenuated
in lungs and spleen (17). This former study thus supports the notion that one or more
genes in the Rv0096-Rv0101 cluster play a role in survival during in vivo infection. In
addition to the ﬁndings obtained with the transposon mutant (17), the study presented
herein characterizes this operon in a more thorough way from in silico to biological
data. Indeed, by using the aerosol route of infection, we show that the nrp cluster is
associated not only with a better transient control but also with altered lung pathol-
ogies and demonstrate its ability to cause delayed mortality in infected immunocom-
petent mice. Accordingly, we show that in immunocompetent hosts, the nrp-deﬁcient
M. tuberculosis strain showed a delayed growth pattern in the lungs during the ﬁrst
20 days of infection compared to that of its WT H37Rv and complemented counter-
parts. This delay in growth at the site of infection was accompanied by the delayed
dissemination of the nrp-deﬁcient M. tuberculosis strain to the spleens of the infected
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mice, improved survival rates, and a lessened pathology even at late stages of infection
and in immunocompromised hosts. This is important, as lung pathology is a major
cause of TB pathogenesis, needed for bacterial transmission and associated with
posttherapy complications (27, 28). Thus, Nrp may be a bacterial modulator of lung
pathology. It is possible that the decreased expression of inﬂammatory molecules, such
as IFN- and TNF, in lungs infected with the nrp-deﬁcient M. tuberculosis strain
contributes to the observed decreased pathology.
Our ﬁndings collectively support a role for nrp during the early phases of the
immune response and demonstrate that M. tuberculosis has evolved to express genes
that manipulate innate defenses. This early role for Nrp during infection ﬁts with a
previous report showing that the in vivo expression of nrp is restricted to the early
phases of infection (18). Accompanying the lower bacterial burden in the lungs of M.
tuberculosis Δnrp-infected mice, we found a delayed recruitment and activation of
inﬂammatory monocytes and CD4 T cells. However, the recruitment of other immune
cell populations was similar between the two infections, possibly suggesting that the
differences observed for inﬂammatory monocytes and CD4 T cells did not result solely
from the reduced bacterial burdens upon M. tuberculosis Δnrp infection. The differential
course of infection in terms of dissemination and pathology caused by the M. tuber-
culosis Δnrp strain may be linked to the differential recruitment of inﬂammatory
monocytes. Previous studies showed that the induction of CCL2 during mycobacterial
infection is associated with the recruitment of permissive monocytes to the lesion,
which then support bacterial growth (21, 29). It is interesting to speculate that, as in the
absence of nrp, CCL2 induction is lower and fewer permissive monocytes are recruited,
and so a lower bacterial burden and less dissemination are observed. On day 30
postinfection, these differences are lost, and similar numbers of inﬂammatory mono-
cytes are present in the lungs of mice infected with either of the M. tuberculosis strains.
The most notable and interesting ﬁnding on the role of nrp in TB pathogenesis came
from the observation that the lack of this gene highly attenuates M. tuberculosis
infection in immunodeﬁcient hosts. We were surprised to discover that RAG2/,
SCID/, and IFN-/ mice infected with the M. tuberculosis Δnrp strain survived
substantially longer than those infected with the complemented counterpart. As shown
in the case of the RAG2/ mice, the growth of M. tuberculosis Δnrp over time was
much slower than that of the complemented strain. This suggests that in the absence
of acquired immunity, the growth of M. tuberculosis Δnrp remains in check, to the
beneﬁt of the host. A similar result is inferred from the infection of IFN-/ mice, as
the bacterial burdens at the time of death were comparable between M. tuberculosis
Δnrp and its complemented counterpart. Most importantly, independent of the genet-
ics of the mouse host, the lung pathology resulting from infection with M. tuberculosis
Δnrp was much less exuberant that that observed for the complemented strain. The
bacterial burden phenotype of theM. tuberculosis Δnrp strain is most likely mediated by
the bacterial interaction with the macrophage. Indeed, we showed that primary mouse
macrophages control the bacterial growth more efﬁciently when nrp is absent. However,
the mechanistic bases of this better control remain unknown but do not seem to depend
on the altered production of, at least, TNF, interleukin 1 (IL-1), and interleukin 10 (IL-10).
Further studies, perhaps encompassing global transcriptional analysis, are thus required to
further explore this observation. As for the in vivo situation, once the macrophages became
fully activated by IFN-, the impact of the absence of nrp is lost.
In all, our ﬁndings highlight a role for the nrp cluster in evading the basic microbi-
cidal mechanisms of the macrophage, which is then overcome by the adaptive immune
response. It is tempting to speculate that the mechanisms that enable this result from
host-pathogen coevolution events. Several outstanding questions arise from this study:
which is the mechanism hijacked by Nrp at the level of innate immunity? How does the
acquired immune response abrogate the impact of Nrp in the macrophage? As an
answer to these questions, the infection of mice deﬁcient for Toll-like receptor 2 (TLR2),
TLR4, IL-10, arachidonate 5-lipoxygenase (ALOX5), or arachidonate 15-lipoxygenase
(ALOX15) with the M. tuberculosis Δnrp strain showed the same phenotype as WT mice
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(see Fig. S5 in the supplemental material). Therefore, basic recognition mechanisms, as
well as an imbalanced anti-inﬂammatory response, do not seem to be associated with
the nrp phenotype. The precise metabolite produced by the nrp cluster in M. tubercu-
losis remains unidentiﬁed, as we were unable to detect an nrp-related metabolite in
lab-grown cultures of M. tuberculosis, and future efforts will likely focus on the identi-
ﬁcation of the product ex vivo in infected tissue. Though challenging, these experi-
ments will enlighten the biological role of the nrp cluster as well as the best timing to
target it from a therapeutic point of view. Despite the importance of pursuing these
questions in the future, our study provides strong evidence linking the nrp cluster to M.
tuberculosis attenuation, speciﬁcally in the context of an immunocompromised host.
Considering the huge impact of the HIV epidemics on TB, our data call for immediate
efforts to be put toward a further understanding of the biological role of Nrp and the
development of therapies targeted to immunocompromised TB patients.
MATERIALS AND METHODS
Comparative genomics. Sequence identity scores were obtained by using the BLAST 2.6.0 (30)
application to search a local database of 72 genomic sequences from species selected to be represen-
tative of the phylogeny of the genus Mycobacterium (19) (NZ_LQOM00000000, NZ_LQOQ00000000,
NZ_LQOR00000000, NZ_LQOS00000000, NZ_LQOT00000000, NZ_LQOY00000000, NZ_ARBU00000000,
NZ_LQPB00000000, NZ_LQPI00000000, NZ_ADNV00000000, NZ_LQPP00000000, NZ_CCAU000000000,
NZ_MIHD00000000, NZ_LQQA00000000, CP000480, GCA_000243415.3_ASM24341v3, GCA_002102065.1_
ASM210206v1, NC_000962, NC_002677, NC_002945, NC_008595, NC_008611, NC_008726, NC_010397,
NC_010612, NC_014814, NC_015564, NC_015576, NC_015758, NC_015848, NC_016604, NC_016946,
NC_018027, NC_018612, NC_019966, NC_020133, NC_021715, NC_022663, NZ_AGVE00000000, NZ_
AJFI00000000, NZ_APKD00000000, NZ_CCBF000000000, NZ_CP007220, NZ_CP011269, NZ_CP011491,
NZ_CP011530, NZ_CP014475, NZ_CP015278, NZ_CP020821, NZ_CSTD00000000, NZ_LQOJ00000000,
NZ_LQOL00000000, NZ_LQOU00000000, NZ_LQOV00000000, NZ_LQOW00000000, NZ_LQOX00000000,
NZ_LQOZ00000000, NZ_LQPC00000000, NZ_LQPD00000000, NZ_LQPE00000000, NZ_LQPF00000000,
NZ_LQPG00000000, NZ_LQPH00000000, NZ_LQPJ00000000, NZ_LQPN00000000, NZ_LQPO00000000,
NZ_LQPQ00000000, NZ_LQPR00000000, NZ_LQPS00000000, NZ_LQPT00000000, NZ_LQPU00000000,
NZ_LQPW00000000, and NZ_LQPX00000000). The database was queried using the sequence of the nrp
cluster (Rv00097-Rv0101) from H37Rv (NC_000962.3). The sequence identity score was calculated by
combining the query coverage, E value, and identity values for each hit with the weights 0.5, 0.25, and
0.25, respectively. A multiple-genome alignment of the sequences NC_002677 (M. leprae), NC_015848
(Mycobacterium canettii), NC_002945 (Mycobacterium bovis) and NC_000962 (M. tuberculosis) was per-
formed using Mauve 2.4.0 (31). The level of nucleotide diversity () was calculated with MEGA7.1.0 (32)
using multiple-sequence alignments of 220 genomic sequences from MTBC strains (lineages 1 to 7) (20).
Construction of a M. tuberculosis H37Rv nrp null mutant. A null mutant of M. tuberculosis H37Rv
nrp (Rv0101) was generated by Specialized Transduction using previously described protocols (33, 34).
Brieﬂy, a derivative of temperature sensitive phage phAE159 was constructed to replace nrp (phΔnrp)
with a hygromycin resistance gene (hyg). Hygromycin resistant colonies obtained following transduction
of M. tuberculosis H37Rv were veriﬁed by Southern blot to conﬁrm the chromosomal replacement of nrp
with hyg. One such transductant was termed Δnrp and used in all subsequent experiments.
Generation of an nrp-complemented strain. A 28-kb M. tuberculosis H37Rv cosmid fragment
(spanning genomic position bp 104933 to bp 133536) was packaged in the integrative shuttle cosmid
vector pYUB412-Kan to generate pYUB2420. This recombinant cosmid spans a region that extends from
Rv0096 to Rv0109. pYUB2420 was introduced into the Δnrp strain by electroporation, and six kanamycin-
resistant transformants were conﬁrmed by Southern blot to contain chromosomally integrated
pYUB2420. One of these transformants, termed nrp-comp, was selected for further studies.
Bacterial growth and stocks. Bacteria were grown in Middlebrook 7H9 liquid medium (BD Biosci-
ences) supplemented with 0.05% Tween 80, 0.2% glycerol, and 10% oleic acid-albumin-dextrose-catalase
(OADC) for 7 to 10 days and then subcultured in Proskauer Beck (PB) medium supplemented with 0.05%
Tween 80 and 2% glycerol to the mid-log phase. Bacterial stocks were aliquoted and frozen at 80°C.
To determine the concentration of M. tuberculosis in aliquots, 6 frozen aliquots were serial diluted and
plated on Middlebrook 7H11 (BD Biosciences) agar plates supplemented with 10% OADC and 0.5%
glycerol. Viable bacteria were determined by CFU enumeration after 21 to 28 days of incubation at 37°C.
Ethics statement. All animal experiments were performed in strict accordance with the recommen-
dations of the European Union Directive 2010/63/EU. All experimental procedures were approved by the
local animal ethics committee, and licensed by the Portuguese National Authority for Animal Health
(DGAV, Portugal) with reference number 014811/2016-07-13. Animal procedures were conducted by
laboratory personnel with accreditation for animal research given by DGAV. The mice were euthanized
by CO2 inhalation, with efforts to minimize suffering.
Mouse strains. C57BL/6 mice were purchased from Charles River Laboratory (Barcelona, Spain).
RAG2-deﬁcient mice were purchased from Instituto Gulbenkian de Ciência (IGC) or generously provided
by Margarida Correia-Neves (ICVS), and IFN- deﬁcient mice were generously provided Susana Roque
(ICVS). All transgenic mice were of a C57BL/6 genetic background. SCID mice were obtained from Charles
River Laboratory (USA).
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Experimental infection. Mice were infected with M. tuberculosis H37Rv (WT), Δnrp, or nrp-comp
strains via the aerosol route by using an inhalation exposure system (Glas-Col), according to previously
published protocols (35, 36), which resulted in the delivery of 100 to 200 viable bacteria to the lungs.
Survival. The weights of the infected mice were determined every week after infection for immu-
nocompetent mice and every week after infection for the ﬁrst 30 days and every 48 h from day 30
postinfection onwards for immunodeﬁcient hosts. Mice were humanely euthanized if they lost 20% of
their maximum weight or upon losing responsiveness to physical stimulation. Whenever possible, the
lungs of moribund animals were harvested for histology and bacterial burden assessment.
Organ processing. At the indicated time points postinfection, the mice were euthanized by CO2
asphyxiation, and the organs were aseptically excised and processed as described previously (35, 36).
Brieﬂy, the lungs were perfused by applying 10 ml phosphate-buffered saline (PBS) through the right
ventricle of the heart to ﬂush blood cells, and single-cell suspensions were prepared in complete
Dulbecco’s modiﬁed Eagle medium (cDMEM; DMEM supplemented with 10% fetal bovine serum [FBS],
glutamine, HEPES, and sodium pyruvate, all from Gibco). Single-cell suspensions were used for bacterial
burden determination, ﬂow cytometry analysis, and RNA extraction. The number of cells was counted
using a Countess automated cell counter (Life Technologies).
Bacterial burden determination. The assessment of initial bacterial burden was performed 3 days
postinfection by growing viable bacteria from whole-lung homogenates. For the other time points, lung
and spleen single-cell suspensions were incubated with 0.1% saponin (Sigma-Aldrich) for 10 min to
release intracellular bacteria. The CFU was determined by plating 10-fold serial dilutions of saponin-
treated cell suspensions on Middlebrook 7H11 agar plates supplemented as described in “Bacterial
growth and stocks.” BBL MGIT PANTA antibiotic mixture (BD Bioscience) was added to prevent the
contamination of lung samples. Viable M. tuberculosis colonies were counted after 21 to 28 days of
incubation at 37°C.
Flow cytometry. Lung cells (1  106 to 2 106) were stained for surface antigens for 30 min at 4°C.
Stained cells were washed and then ﬁxed overnight in PBS containing 2% paraformaldehyde. The
following antibodies were used: CD3-PE (clone 145-2C11; eBioscience), CD4-PB (clone RM4-5; eBiosci-
ence), CD8-FITC (clone 5H10-1; BioLegend), CD44-PerCPCy5.5 (clone 1M7; eBioscience), CD62L-PECy7
(clone MEL-14; BioLegend), CD19-APC (clone eBio1D3; eBioscience), Ly6G-APC (clone 1A8; BioLegend),
Ly6C-PerCPCy5.5 (clone AL-21; BD Pharmingen), MHC II-FITC (clone AMS-32.1; BD Pharmingen),
CD11b-PE (clone M1/70; BioLegend), and CD11c-PB (clone N418; BioLegend). Samples were run on an
LSRII ﬂow cytometer with Diva software, and the data were analyzed using FlowJo version 10.1.r7
software. The total number of cells in each gate was calculated using the total number of cells
determined by the Countess automated cell counter. The gating strategy used is shown in Fig. S2 in the
supplemental material.
RNA extraction, reverse transcription, and real-time PCR. Total RNA from infected lungs was
extracted with TRIzol reagent (Invitrogen), and cDNA was synthesized and analyzed by real-time PCR, as
described previously (35, 36). Target IFN- and TNF mRNA expression was quantiﬁed using SYBR green
(GrisP) and speciﬁc oligonucleotides and normalized to the ubiquitin mRNA levels. The expression of
CCL2 and CCL7 was quantiﬁed using speciﬁc primer-probe sets (Applied Biosystems) and normalized to
the expression of hypoxanthine phosphoribosyltransferase (HPRT).
Histology analysis. The right upper lobes of the lungs were ﬁxed in PBS containing 3.7% formal-
dehyde, embedded in parafﬁn, sectioned in 2- to 3 -m-thick slices, and stained with hematoxylin-eosin
(35). The lung surface area of inﬂammation was measured using ImageJ software (version 1.50e; NIH). The
percentage of total lung area involved with inﬂammation was calculated by dividing the cumulative area
of inﬂammation by the total lung surface area for each sample.
Infection of bone marrow-derived macrophages and peritoneal macrophages. BMDM were
differentiated from bone marrow cells obtained from the femurs and tibiae of C57BL/6 mice and cultured
in the presence of L-cell conditioned medium, as described previously (37). pMac were obtained by
intraperitoneally injecting 1 ml of thioglycolate into WT C57BL/6 mice. After 4 days, the mice were
euthanized and the peritoneums were washed with PBS. In both cases, 1  106 cells were infected with
Δnrp or nrp-comp strains at a multiplicity of infection (MOI) of 1 bacteria to 1 macrophage. Four hours
after infection, the cells were washed 4 times with PBS (Gibco) to remove extracellular bacteria. The
adherent cells were cultured at 37°C in 1 ml of cDMEM in the presence or absence of 100 U/ml of IFN-
for 96 h. Four or ninety-six hours postinfection, 0.1% saponin (Sigma-Aldrich) in PBS was added to the
wells, and the cells were incubated at room temperature (RT) for 10 min to release intracellular bacteria.
The number of viable bacteria was determined by plating 10-fold serial dilutions of the saponin-treated
cell suspensions on supplemented Middlebrook 7H1 agar, as described in “Bacterial growth and stocks.”
Cytokine determination by ELISA. TNF, IL-1, and IL-10 concentrations in the supernatants of
infected macrophages were determined 24 h postinfection by enzyme-linked immunosorbent assays
(ELISAs) with commercially available kits (eBioscience), according to the manufacturer’s instructions.
Cytokine levels from uninfected cells were below the assay level of detection (not shown).
Cell viability assay. Cell viability was determined in noninfected or infected macrophages 2 or
4 days postinfection. Macrophages were gently detached from low-adherence tissue culture plates using
a cell scraper. Cell viability was assessed by using trypan blue exclusion.
Statistical analysis. Data were analyzed using GraphPad Prism 6. The differences between groups
were analyzed with two-way analyses of variance (ANOVAs) using Sidak’s tests for multiple comparisons.
Kaplan-Meier survival curves were analyzed with the log-rank (Mantel-Cox) test. Differences were
considered signiﬁcant at P values of 0.05.
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SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mSphere.00352-18.
FIG S1, TIF ﬁle, 1 MB.
FIG S2, TIF ﬁle, 0.7 MB.
FIG S3, TIF ﬁle, 0.1 MB.
FIG S4, TIF ﬁle, 0.1 MB.
FIG S5, TIF ﬁle, 0.2 MB.
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